Caution on the use of altered fractionation for nasopharyngeal carcinoma.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 10580865.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Randomized trials and overviews on the value of altered fractionation for head and neck cancers are reviewed. Attention is drawn to the unexpectedly high incidence of temporal lobe necrosis incurred in patients with nasopharyngeal carcinoma. Preliminary analyses suggest that incomplete repair is likely to be the major factor, even a 6-h interfraction interval may be inadequate if substantial volumes of nervous tissues are included within the target volume.
Medical subject headings
- Carcinoma
- Dose Fractionation, Radiation
- Nasopharyngeal Neoplasms
- Radiotherapy Dosage